Orchid Pharma Ltd Closes Trading Window for Q2 FY27 Results

Orchid Pharma Ltd has announced the closure of its trading window for the second quarter of the financial year 2026-27, which ends on September 30, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results (standalone and consolidated) for the aforementioned quarter. The specific date for the Board of Directors' meeting to approve these results will be communicated separately. All individuals in possession of unpublished price-sensitive information are prohibited from trading in the company's securities during this period.